Trade CLRB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cellectar Biosciences, Inc. (CLRB) is trading at US$2.31, down 2.53% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$24.48M. Over the past 52 weeks, CLRB has traded between US$2.20 and US$6.52. On Syfe you can trade CLRB with $0 commission and add it to your watchlist.
| Previous close | US$2.37 |
|---|---|
| Market cap | US$24.48M |
| 52-week range | US$2.20 – US$6.52 |
| Volume | 38.2K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded on June 24, 1996 and is headquartered in Florham Park, NJ.
Year: 2005
Cellectar Biosciences Files for Secondary Offering of Common Shares
May 19, 9:24 PM · MT Newswires
Cellectar Biosciences, Inc. (CLRB) stock is trading at US$2.31, -2.53% from the previous close of US$2.37.
The market cap for Cellectar Biosciences, Inc. (CLRB) stock is approximately US$24.48M.
The 52-week high for Cellectar Biosciences, Inc. (CLRB) stock is US$6.52.
The 52-week low for Cellectar Biosciences, Inc. (CLRB) stock is US$2.20.
Cellectar Biosciences, Inc. (CLRB) does not currently pay a dividend.
Stay on top of CLRB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
